Small Acute Increases in Serum Creatinine are Associated with Decreased Long Term Survival in the Critically Ill.

Link to article at PubMed

Related Articles

Small Acute Increases in Serum Creatinine are Associated with Decreased Long Term Survival in the Critically Ill.

Am J Respir Crit Care Med. 2014 Mar 6;

Authors: Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH

Abstract
Rationale: Long-term outcome after acute kidney injury (AKI) are poorly described. Objective: We hypothesized that one single episode of minimal (stage I) AKI is associated with reduced long-term survival compared to no acute kidney injury (No AKI) following recovery from critical illness. Methods: A prospective cohort of intensive care unit patients (ICU) of 2010 patients admitted to the ICU between year 2000 and 2009 at a provincial tertiary care hospital. Development of AKI was determined according to the KDIGO classification and mortality up to 10 years after ICU admission was recorded. Main results: Of the 1844 eligible patients, 18.4% had AKI stage 1, 12.1% had stage 2, 26.5% had stage 3, and 43.0% had No AKI. The 28-day, 1-year, 5-year and 10-year survival rates were 67.1%, 51.8%, 44.1%, and 36.3%, in patients with mild AKI, which was significantly worse compared to the critically ill patients with no AKI at any time (P<0.01). The unadjusted 10-year mortality hazard ratio was 1.53 (95% CI 1.2-2.0) for 28-day survivors with stage 1 AKI compared to critically ill patients with no AKI. Adjusted 10-year mortality risk was 1.26 (1.0 to 1.6). After propensity matching stage 1 AKI with no AKI patients, mild AKI was still significantly associated with decreased 10-year survival (P=0.036). Conclusions: Patients with one episode of mild AKI have significantly lower long-term survival rates than critically ill patients with No AKI. Close medical follow-up of these patients may be warranted and mechanistic research is required to understand how AKI influences long-term events.

PMID: 24601781 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *